Cargando…
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
SIMPLE SUMMARY: Disease outcome of patients with pseudomyxoma peritonei (PMP) and appendiceal neoplasms improved gradually in the past decades, as their pathology is better understood, together with a refined subtypisation. The introduction of cytoreductive surgery and hyperthermic intraperitoneal c...
Autores principales: | Blaj, Sebastian, Dora, David, Lohinai, Zoltan, Herold, Zoltan, Szasz, Attila Marcell, Herzberg, Jonas, Kodacsi, Roland, Baransi, Saher, Schlitt, Hans Jürgen, Hornung, Matthias, Werner, Jens M., Slowik, Przemyslaw, Acs, Miklos, Piso, Pompiliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954733/ https://www.ncbi.nlm.nih.gov/pubmed/36831667 http://dx.doi.org/10.3390/cancers15041326 |
Ejemplares similares
-
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023) -
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022) -
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022) -
Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009) -
Approach to pseudomyxoma peritonei
por: Rizvi, Syed Ali, et al.
Publicado: (2018)